The potential of NAA40 to serve as a target in anticancer therapy is also reinforced by the data here which show its ability to sensitize CRC cancer cells toward conventional chemotherapeutic drugs such as 5-FU (Fig. 3c). This evidence concerns the gene NAA40 and cancer.